Matrisome Bio Overview
- Year Founded
-
2023
- Status
-
Private
- Employees
-
10
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$100K
- Investors
-
7
Matrisome Bio General Information
Description
Developer of an extracellular matrix-targeting therapeutic platform designed for the treatment of cancer and chronic diseases. The company's platform utilizes proprietary nanobody libraries to deliver therapeutic payloads directly to the extracellular matrix of tumors and metastases, enabling healthcare providers to treat solid tumors and fibrotic lesions through a stable and abundant target that remains consistent across different patients and disease sites.
Contact Information
Website
www.matrisomebio.comCorporate Office
- 700 Main Street
- Cambridge, MA 02139
- United States
Corporate Office
- 700 Main Street
- Cambridge, MA 02139
- United States
Matrisome Bio Timeline
Matrisome Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Grant | 13-Aug-2026 | $100K | Completed | Startup | ||
| 5. Accelerator/Incubator | 01-Jan-2025 | Completed | Startup | |||
| 4. Seed Round | 15-Dec-2023 | Completed | Startup | |||
| 3. Accelerator/Incubator | 13-Oct-2023 | Completed | Startup | |||
| 2. Accelerator/Incubator | 01-Feb-2023 | $6M | Completed | Startup | ||
| 1. Seed Round | 17-Jan-2023 | $6M | $6M | Completed | Startup |
Matrisome Bio Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Matrisome Bio Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Matrisome Bio Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Matrisome Bio Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| MassVentures | Venture Capital | Minority | ||
| Termeer Institute | Accelerator/Incubator | |||
| BOLD Capital Partners | Venture Capital | Minority | ||
| Pacific 8 Ventures | Venture Capital | Minority | ||
| Endless Frontier Labs | Accelerator/Incubator |
Matrisome Bio FAQs
-
When was Matrisome Bio founded?
Matrisome Bio was founded in 2023.
-
Where is Matrisome Bio headquartered?
Matrisome Bio is headquartered in Cambridge, MA.
-
What is the size of Matrisome Bio?
Matrisome Bio has 10 total employees.
-
What industry is Matrisome Bio in?
Matrisome Bio’s primary industry is Biotechnology.
-
Is Matrisome Bio a private or public company?
Matrisome Bio is a Private company.
-
What is Matrisome Bio’s current revenue?
The current revenue for Matrisome Bio is .
-
How much funding has Matrisome Bio raised over time?
Matrisome Bio has raised $9.7M.
-
Who are Matrisome Bio’s investors?
MassVentures, Termeer Institute, BOLD Capital Partners, Pacific 8 Ventures, and Endless Frontier Labs are 5 of 7 investors who have invested in Matrisome Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
